We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 9,215 results
  1. Intranasal and Inhaled Vaccines

    Many respiratory infections have epidemic and pandemic potential, as evidenced by influenza and the recent COVID-19 pandemic. Vaccination is an...
    Michael Yee-Tak Chow, Jenny Ka Wing Lam in Respiratory Delivery of Biologics, Nucleic Acids, and Vaccines
    Chapter 2023
  2. Intranasal Pressure Recording for Monitoring Mouse Respiration

    Respiration is a highly dynamic signal that influences voluntary behaviors including odor sampling and entrains rhythmic activity in the brain. Many...
    Emma Janke, Janardhan P. Bhattarai, Minghong Ma in The Olfactory System
    Protocol 2023
  3. Intranasal insulin effect on cognitive and/or memory impairment: a systematic review and meta-analysis

    Background: Cognitive impairment, characterized by deficits in cognitive functions and loss of delayed and immediate recall, disproportionately...

    María Dolores Gómez-Guijarro, Iván Cavero-Redondo, ... Irene Martínez-García in Cognitive Neurodynamics
    Article 13 June 2024
  4. Nanovesicular-Mediated Intranasal Drug Therapy for Neurodegenerative Disease

    Numerous neurodegenerative conditions, such as Alzheimer’s, Huntington’s, Parkinson’s, amyotrophic lateral sclerosis, and glioblastoma multiform are...

    Shalu Singh, Rahul Shukla in AAPS PharmSciTech
    Article 02 September 2023
  5. Post-exposure intranasal IFNα suppresses replication and neuroinvasion of Venezuelan Equine Encephalitis virus within olfactory sensory neurons

    Background

    Venezuelan Equine Encephalitis virus ( VEEV) may enter the central nervous system (CNS) within olfactory sensory neurons (OSN) that...

    Matthew D. Cain, N. Rubin Klein, ... Robyn S. Klein in Journal of Neuroinflammation
    Article Open access 17 January 2024
  6. In-depth Mechanism, Challenges, and Opportunities of Delivering Therapeutics in Brain Using Intranasal Route

    Central nervous system-related disorders have become a continuing threat to human life and the current statistic indicates an increasing trend of...

    Arya Ghosh, Ankit Majie, ... Bapi Gorain in AAPS PharmSciTech
    Article 06 May 2024
  7. Intranasal Monophosphoryl Lipid a Administration Ameliorates depression-like Behavior in Chronically Stressed Mice Through Stimulation of Microglia

    We and others have reported that systematic stimulation of the central innate immune system by a low dose of lipopolysaccharide (LPS) can improve...

    Meng Zheng, Tao Zhu, ... Chao Huang in Neurochemical Research
    Article 26 June 2023
  8. Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties

    Targeting drugs to the mitochondrial level shows great promise for acute and chronic treatment of traumatic brain injury (TBI) in both military and...

    Jignesh D. Pandya, Sudeep Musyaju, ... Deborah A. Shear in Journal of Translational Medicine
    Article Open access 16 February 2024
  9. Intranasal delivery of siRNA targeting NR2B attenuates cancer-associated neuropathic pain

    Purpose

    This study aimed to reduce cancer-associated pain by blocking pain signals through the intranasal administration of siRNA targeting the NMDA...

    Kunho Chung, Hyoung-Gon Ko, ... Sang-Kyung Lee in Journal of Pharmaceutical Investigation
    Article 13 February 2024
  10. Significance of Intranasal Drug Delivery Systems: Recent Trends and Clinical Investigations in Brain Disorders

    Intranasal drug administration has enormous research potential, including both drugs designed specifically for intranasal use and off-label...
    Deepshi Arora, Shailendra Bhatt, ... Muskan Chauhan in Recent Advances in Pharmaceutical Innovation and Research
    Chapter 2023
  11. Intranasal inorganic cerium oxide nanoparticles ameliorate oxidative stress induced motor manifestations in haloperidol-induced parkinsonism

    Cerium oxide nanoparticles (CONPs), owing to their radical scavenging property, have recently emerged as a therapeutic candidate for oxidative...

    Mohammad, Urooj Ahmed Khan, ... Asgar Ali in Inflammopharmacology
    Article 11 July 2023
  12. Intranasal vaccination with an NDV-vectored SARS-CoV-2 vaccine protects against Delta and Omicron challenges

    The rapid development and deployment of vaccines following the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been...

    Bryce M. Warner, Jacob G. E. Yates, ... Darwyn Kobasa in npj Vaccines
    Article Open access 23 May 2024
  13. Re-examining Naloxone Pharmacokinetics After Intranasal and Intramuscular Administration Using the Finite Absorption Time Concept

    Background and Objectives

    Naloxone for opioid overdose treatment can be administered by intravenous injection, intramuscular injection, or intranasal...

    Athanasios A. Tsekouras, Panos Macheras in European Journal of Drug Metabolism and Pharmacokinetics
    Article 02 June 2023
  14. The Synergistic Effect Study of Lipopolysaccharide (LPS) and A53T-α-Synuclein: Intranasal LPS Exposure on the A53T-α-Synuclein Transgenic Mouse Model of Parkinson’s Disease

    Aging and interactions between genetic and environmental factors are believed to be involved the chronic development of Parkinson’s disease (PD)....

    Qing He, Shuzhen Zhang, ... Wei Chen in Molecular Neurobiology
    Article 17 February 2024
  15. Nanoemulsions and nanocapsules as carriers for the development of intranasal mRNA vaccines

    The global emergency of coronavirus disease 2019 (COVID-19) has spurred extensive worldwide efforts to develop vaccines for protection against severe...

    Mireya L. Borrajo, Gustavo Lou, ... María José Alonso in Drug Delivery and Translational Research
    Article Open access 29 May 2024
  16. Phase III Pivotal comparative clinical trial of intranasal (iNCOVACC) and intramuscular COVID 19 vaccine (Covaxin®)

    One of the most preferable characteristics for a COVID-19 vaccine candidate is the ability to reduce transmission and infection of SARS-CoV-2, in...

    Chandramani Singh, Savita Verma, ... Krishna Mohan Vadrevu in npj Vaccines
    Article Open access 18 August 2023
  17. Intranasal administration of Lactobacillus johnsonii attenuates hyperoxia-induced lung injury by modulating gut microbiota in neonatal mice

    Background

    Supplemental oxygen impairs lung development in newborn infants with respiratory distress. Lactobacillus johnsonii supplementation...

    Chung-Ming Chen, Yu-Chen S. H. Yang, ... Shan Lin in Journal of Biomedical Science
    Article Open access 31 July 2023
  18. The Effect of Intranasal Administration of Gangliosides on the Viability of CA1 Hippocampal Neurons in Rat Two-Vessel Occlusion Model of Forebrain Ischemia/Reperfusion Injury

    Intranasal administration of total bovine brain gangliosides (6 mg/kg) to rats protected the CA1 hippocampal neurons from the death caused by...

    D. K. Avrova, L. V. Bayunova, ... I. O. Zakharova in Bulletin of Experimental Biology and Medicine
    Article 01 April 2024
  19. Intranasal vaccine for Lyme disease provides protection against tick transmitted Borrelia burgdorferi beyond one year

    Strategies for disease control are necessary to reduce incidence of Lyme Disease (LD) including development of safe vaccines for human use....

    Maria Cristina Gingerich, Nisha Nair, ... Maria Gomes-Solecki in npj Vaccines
    Article Open access 15 February 2024
  20. Stem Cell Therapy for Ischemic Brain Injury: Early Intranasal Delivery after Cardiac Arrest

    Global ischemic brain injury is the leading cause of mortality and long-term disability in patients resuscitated from cardiac arrest. Hypothermia and...

    **ao Liu, **aofeng Jia in Translational Stroke Research
    Article 04 April 2023
Did you find what you were looking for? Share feedback.